Foley & Lardner LLP Partner Kyle Faget explains the underlying intent and purpose of the federal Anti-Kickback Statute in a four-part video series for LexisNexis Practical Guidance. In the videos, she discusses the protection of federal health care programs, the scope and elements of the law, statutory exceptions, and other laws implicated. Excerpts from the videos are below.
- Federal Anti-Kickback Statute: Protecting Federal Health Care Programs
- Federal Anti-Kickback Statute: Scope and Elements of the Law
- Federal Anti-Kickback Statute: Statutory Exceptions
- Federal Anti-Kickback Statute: Other Laws Implicated
Faget is co-chair of Foley’s Health Care and Life Sciences Practice Groups.
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."